Ocid-D Capsule is indicated for treating GERD (Gastro-esophageal reflux disease), which does not respond to Omeprazole medications alone. It prevents the tendency of vomiting and nausea in people suffering from gastrointestinal problems.
Ocid-D Capsule is a combination of Domperidone and Omeprazole. The active ingredients fall under the class of dopamine antagonist and PPI (Proton pump inhibitor), respectively.
It is also prescribed to the patients of peptic ulcer and who take certain medicines for Parkinson’s disease. The medicine tightens the muscles near the entrance of the stomach and relaxes the ones present at the exit.
The action of this medication helps to speed up the passing of the food that you intake – from your stomach to your intestine, reducing the feeling of nausea and sickness, also preventing vomiting.
Ocid D medicine also works by blocking or reducing the stimulation in the ‘vomiting centre’ of your brain, which will eventually reduce the feeling of nausea and vomiting. The possible side effects of taking this medication can be headache, migraine, dryness of the mouth or breast pain.
You are advised not to take Ocid-D Capsule if you have the following conditions:
An allergy to Ocid-D Capsule or any other ingredient of this medicine
Bleeding problems or blockage in your stomach or in the intestine
Tumour in the pituitary gland
Incorrect levels of magnesium, potassium or calcium in the blood
Severe /moderate liver impairment
Ocid D Capsule is primarily used for the following conditions:
Gastroesophageal Reflux Disease
Possible side effects of Ocid D Capsule are as follows:
Are there any missed dose instructions?
Take the missed dose as soon as possible. If it is almost time for the next dose, skip the dose and follow the regular schedule.
Are there any overdose instructions?
Seek emergency medical treatment or contact the doctor in case of an overdose.
Ocid D Capsule attaches to the dopaminergic receptors without causing any release of the chemical dopamine. It, in turn, facilitates gastric emptying and decreases small bowel transit time. Also, it binds to H+/K+-exchanging ATPase in gastric parietal cells, resulting in blockage of acid secretion.